These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8986603)

  • 21. A novel nuclear export activity in HIV-1 matrix protein required for viral replication.
    Dupont S; Sharova N; DéHoratius C; Virbasius CM; Zhu X; Bukrinskaya AG; Stevenson M; Green MR
    Nature; 1999 Dec; 402(6762):681-5. PubMed ID: 10604476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase.
    Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI
    Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
    Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
    Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene.
    Lockett LJ; Both GW
    Virology; 2002 Mar; 294(2):333-41. PubMed ID: 12009875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus type 2 nuclear RNA accumulating during productive infection.
    Bachenheimer SL
    J Virol; 1977 May; 22(2):577-82. PubMed ID: 864839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus infection targets the cellular protein kinase CK2 and RNA-activated protein kinase (PKR) into viral inclusions of the cell nucleus.
    Souquere-Besse S; Pichard E; Filhol O; Legrand V; Rosa-Calatrava M; Hovanessian AG; Cochet C; Puvion-Dutilleul F
    Microsc Res Tech; 2002 Mar; 56(6):465-78. PubMed ID: 11921349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system.
    Nagayama Y; Nishihara E; Namba H; Yokoi H; Hasegawa M; Mizuguchi H; Hayakawa T; Hamada H; Yamashita S; Niwa M
    Cancer Gene Ther; 2001 Jan; 8(1):36-44. PubMed ID: 11219492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Replication of adenovirus DNA].
    Ikeda JE
    Tanpakushitsu Kakusan Koso; 1982; 27(16):2440-6. PubMed ID: 6761788
    [No Abstract]   [Full Text] [Related]  

  • 29. Organization of splicing factors in adenovirus-infected cells reflects changes in gene expression during the early to late phase transition.
    Aspegren A; Rabino C; Bridge E
    Exp Cell Res; 1998 Nov; 245(1):203-13. PubMed ID: 9828117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
    Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
    Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular uptake and nuclear delivery of recombinant adenovirus penton base.
    Hong SS; Gay B; Karayan L; Dabauvalle MC; Boulanger P
    Virology; 1999 Sep; 262(1):163-77. PubMed ID: 10489350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear actin and myosins in adenovirus infection.
    Fuchsova B; Serebryannyy LA; de Lanerolle P
    Exp Cell Res; 2015 Nov; 338(2):170-82. PubMed ID: 26226218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous occurrence of early region 1A reiteration mutants of type 5 adenovirus in persistently infected human T-lymphocytes.
    Tang Q; Lundholm-Beauchamp U; Ginsberg HS
    Virology; 1997 Apr; 230(2):281-91. PubMed ID: 9143284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative microscopy of fluorescent adenovirus entry.
    Nakano MY; Greber UF
    J Struct Biol; 2000 Feb; 129(1):57-68. PubMed ID: 10675297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral and cellular interactions during adenovirus DNA replication.
    Charman M; Herrmann C; Weitzman MD
    FEBS Lett; 2019 Dec; 593(24):3531-3550. PubMed ID: 31764999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear perturbations following adenovirus infection.
    Russell WC; Matthews DA
    Curr Top Microbiol Immunol; 2003; 272():399-413. PubMed ID: 12747557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hypoxia on Ad5 infection, transgene expression and replication.
    Shen BH; Hermiston TW
    Gene Ther; 2005 Jun; 12(11):902-10. PubMed ID: 15690062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of adenovirus RNA synthesized in the presence of an adenosine analog: failure of poly(A) addition.
    Swart C; Hodge LD
    Virology; 1978 Feb; 84(2):374-89. PubMed ID: 622805
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional characterization of the major late promoter of mouse adenovirus type 1.
    Song B; Young CS
    Virology; 1997 Aug; 235(1):109-17. PubMed ID: 9300042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.
    Thomas MA; Spencer JF; La Regina MC; Dhar D; Tollefson AE; Toth K; Wold WS
    Cancer Res; 2006 Feb; 66(3):1270-6. PubMed ID: 16452178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.